Additional questions on the investor q&a: OptiMAL® Launch
Please submit additional questions below and the management team will answer and share questions in due course.
View the webinar recording here
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Fusion Antibodies plc. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Fusion Antibodies plc a question about this update.